Seth Rudnick

Insider Reports History

Entity
Individual
Location
7100 West Credit Avenue, Suite 101, C/O Aralez Pharmaceuticals, Mississauga, Ontario, Canada
Signature
/s/ James Stillman Hanson, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Seth Rudnick:

Stock Role Class Num Shares Value Price $ Report Date Ownership
G1 Therapeutics, Inc. Director Common Stock 5.27K $15.5K $2.94 Jun 29, 2021 Indirect
G1 Therapeutics, Inc. Director Common Stock 4.39K $12.9K $2.94 Jun 29, 2021 Direct
G1 Therapeutics, Inc. Director Stock Options (Right to Buy) 0 Jun 29, 2021 Direct

Insider Reports Filed by Seth Rudnick

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GTHX G1 Therapeutics, Inc. Jun 29, 2021 5 -$220K 4 Jun 30, 2021 Director
GTHX G1 Therapeutics, Inc. Jun 17, 2021 2 $0 4 Jun 21, 2021 Director